Show simple item record

dc.contributor.authorChamberlain, Janet
dc.contributor.authorWheatcroft, Mark
dc.contributor.authorArnold, Nadine
dc.contributor.authorLupton, Henry
dc.contributor.authorCrossman, David C.
dc.contributor.authorGunn, Julian
dc.contributor.authorFrancis, Sheila
dc.date.accessioned2018-09-20T16:03:00Z
dc.date.available2018-09-20T16:03:00Z
dc.date.issued2009-07-25
dc.identifier.citationChamberlain, Janet; Wheatcroft, Mark; Arnold, Nadine; Lupton, Henry; Crossman, David C. Gunn, Julian; Francis, Sheila (2009). A novel mouse model of in situ stenting. Cardiovascular Research 85 (1), 38-44
dc.identifier.issn1755-3245,0008-6363
dc.identifier.urihttp://hdl.handle.net/10379/10737
dc.description.abstractAims Animal models of stenting are mostly limited to larger animals or involve substantial abdominal surgery in rodents. We aimed to develop a simple, direct model of murine stenting. Methods and results We designed a miniature, self-expanding, nitinol wire coil stent that was pre-loaded into a metal stent sheath. This was advanced into the abdominal aorta of the mouse, via femoral access, and the stent deployed. In-stent restenosis was investigated at 1, 3, 7, and 28 days post-stenting. The model was validated by investigation of neointima formation in mice deficient in signalling via the interleukin-1 receptor (IL-1R1), compared with other injury models. Ninety-two per cent of mice undergoing the procedure were successfully stented. All stented vessels were patent. Inflammatory cells were seen in the adventitia and around the stent strut up to 3 days post-stenting. At 3 days, an early neointima was present, building to a mature neointima at 28 days. In mice lacking IL-1R1, the neointima was 64% smaller than that in wild-type controls at the 28-day timepoint, in agreement with other models. Conclusion This is the first description of a successful model of murine in situ stenting, using a stent specifically tailored for use in small thin-walled arteries. The procedure can be undertaken by a single operator without the need for an advanced level of microsurgical skill and is reliable and reproducible. The utility of this model is demonstrated by a reduction in in-stent restenosis in IL-1R1-deficient mice.
dc.publisherOxford University Press (OUP)
dc.relation.ispartofCardiovascular Research
dc.subjectmouse stent model
dc.subjectballoon angioplasty
dc.subjectneointimal formation
dc.subjectporcine model
dc.subjectrat model
dc.subjectrestenosis
dc.subjectinjury
dc.subjectmice
dc.subjectatherosclerosis
dc.subjectinterleukin-1
dc.subjectimplantation
dc.titleA novel mouse model of in situ stenting
dc.typeArticle
dc.identifier.doi10.1093/cvr/cvp262
dc.local.publishedsourcehttps://academic.oup.com/cardiovascres/article-pdf/85/1/38/17198766/cvp262.pdf
nui.item.downloads0


Files in this item

This item appears in the following Collection(s)

Show simple item record